期刊文献+

多囊卵巢综合征患者血清脂联素水平与胰岛素抵抗的关系 被引量:4

The relationship of plasma adiponectin level and insulin resistance in patients with polycystic ovary syndrome
原文传递
导出
摘要 目的:探讨多囊卵巢综合征(PCOS)患者血清脂联素水平与胰岛素抵抗的相关性。方法:58例P-COS患者根据体质指数分为肥胖组28例和非肥胖组30例,并选择30例正常同龄妇女为对照。比较血清脂联素(APN)、胰岛素(FINS)、瘦素(Leptin)及HOMA-IR水平。结果:PCOS组血清脂联素水平为7.24±2.36 ng/ml,明显低于对照组的14.86±3.67 ng/ml,P<0.01;多囊卵巢综合征肥胖组脂联素水平为5.8±2.8 ng/ml,明显低于非肥胖者的9.8±2.4 ng/ml,P<0.01;多囊卵巢综合征组肥胖、非肥胖者脂联素水平与体重指数(BMI)、胰岛素抵抗指数(HOMA-IR)、腰臀比(WHR)呈负相关,差异有统计学意义(P<0.01)。结论:PCOS患者血清脂联素水平降低,可能与肥胖、胰岛素抵抗相关,可以作为PCOS发生糖尿病远期并发症的预测指标。 Objective:To investigate potential association of plasma adiponectin with insulin resistance in polycystic ovary syndrome patients(PCOS).Methods: PCOS patients(58) were divided into obese group(28) and non-obese group(30).Normal females(30) in their reproductive ages were recruited as controls.Plasma adiponectin,leptin,fasting insulin and HOMA-IR were measured and the results were compared among the groups.Results: While the level of APN in PCOS group(7.24±2.36 ng/ml) was significantly lower than that in the controls(14.86±3.67 ng/ml,P0.01).Furthermore,the APN level of obese group(5.8±2.8 ng/ml) was lower than that of non-obese group(9.8±2.4 ng/ml,P0.01).A negative correlation(P0.01) between APN and other indices(BMI,WHR and HOMA-RI) was observed in both obese and non-obese groups.Conclusion: Lower APN level in PCOS patients was associated with obesity and insulin resistance,and thus it can be a prognostic index for diabetes.
作者 叶玲玲
出处 《中国卫生检验杂志》 北大核心 2012年第11期2628-2629,共2页 Chinese Journal of Health Laboratory Technology
关键词 多囊卵巢综合征 脂联素 胰岛素抵抗 Polycystic ovary syndrome Adiponectin Insulin resistance
  • 相关文献

参考文献7

  • 1黄宇虹,高秀梅,张伯礼.脂联素的研究进展[J].中国临床药理学与治疗学,2004,9(9):961-965. 被引量:17
  • 2Rotterdam ESHRE/ASRM - Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long - term health risks related to polycystic ovary syndrome [ J ]. Fertil Steril, 2004, 81(1) :19 -25.
  • 3Benson SA, Janssen OEB, Hahn SC, et al. Obesity, depression, and chronic low - grade inflammation in women with polycystic ovary syn- drome[J]. Behav Immun, 2008, 22(2):177 -184.
  • 4Kondo H, Shimomura I, Mastsukawa Y, et al. Association of adipone- ctin mutation with type 2 diabetes : a candidate gene for the insulin re- sistance syndrome[ J]. Diabetes, 2002, 51:2325 - 2328.
  • 5Kershaw EE, Flier JS. Adipose tissue as an endocrine organ[J]. J Clin Endocrinol Metab, 2004, 89 (6) : 2548 - 2556.
  • 6Faraj M, Havel PJ, Phelis S, et al. Plasma acylation stimulating pro- tein, adiponectin, leptin, and ghrelin before and after weight loss in- duced by gastric bypass surgery in morbidly obese subjects[Jl. J Clin Endocrinol Metab, 2003, 88 (4) : 159 - 160.
  • 7Shroff R, Kerchner A, Maifeld M, et al. Young obese women with poiycystic ovary syndrome have evidence of early coronary atherosclero- sis [ J ]. J Clin Endocrinol Metab, 2007, 92 ( 12 ) :4609 - 4614.

二级参考文献30

  • 1[1]Scheen AJ. Pathophysiology of type 2 diabetes [ J]. Acta Clin Belg, 2003; 58(6): 335-41
  • 2[2]Takahashi M, Arita Y, Yamagata K. Genomic structure and mutations in adipose-specific gene, adiponectin[J]. Int J Obse, 2000; 24: 861- 8
  • 3[3]Saito K, Tobe T, Minoshima. Organization of the gene for gelatin-binding protein(GBP28) [J]. Gene, 1999; 229( 1 - 2): 67- 73
  • 4[4]Hare K, Boutin P, Mori Y. Genetic variation in the gene encoding adiponectin is associated risk of type 2 diabetes in the Japanese population[J]. Diabetes, 2002; 51(4): 1294
  • 5[5]Ohashi K, Ouchi N, Kihara S, Funahashi T, Nakamura T,Sumitsuji S, et al. Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease[J]. J Am Coll Cardiol, 2004; 43(7): 1195-200
  • 6[6]Vasseur F, Helbecque N, Dina C. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipoctye-secreted adiponectin hormone levels and contributes to the genetic risk for type 2 diabetes in French Caucasians[J]. Hum Mol Genet, 2002; 11(21):2607 - 14
  • 7[7]Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, et al. Adiponectin acts in the brain to decrease body weight[J]. Nat Med, 2004; 10(5): 524- 9
  • 8[8]Furukawa K, Hori M, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, et al. Adiponectin down-regulates acylcoenzyme A:cholesterol acyltransferase-1 in cultured human monocyte-derived macrophages[J]. Biochem Biophys Res Commun, 2004; 317(3): 831 - 6
  • 9[9]Maruyoshi H, Kojima S, Funahashi T, Miyamoto S, Hokamaki J, Soejima H, et al. Adiponectin is inversely related to plasminogen activator inhibitor type 1 in patients with stable exertional angina[J]. Thromb Haemost, 2004; 91(5): 1026-30
  • 10[10]Komatsu M, Ohfusa H, Sato Y, Yajima H, Yamauchi K,Aizawa T, et al. Strong inverse correlation between serum adiponectin level and heart rate-corrected QT interval in an apparently healthy population: A suggestion for a direct antiatherogenic effect of adiponectin[J]. Diabetes Care, 2004; 27(5):1237 - 8

共引文献16

同被引文献31

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部